Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing
The American Journal of Clinical Nutrition · 2024-09 · 120 (3) · 664-673
DOI: 10.1016/j.ajcnut.2024.07.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Clinical Nutrition, 2024-09. Verfasst von Elom K Aglago und 42 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Imperial College London, School of Public Health, London, United Kingdom. Electronic address: k.aglago@…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Folic Acid, Mutation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, World Health Organization.
Abstract (Originalsprache)
BACKGROUND: Folate is involved in multiple genetic, epigenetic, and metabolic processes, and inadequate folate intake has been associated with an increased risk of cancer. OBJECTIVE: We examined whether folate intake is differentially associated with colorectal cancer (CRC) risk according to somatic mutations in genes linked to CRC using targeted sequencing. DESIGN: Participants within 2 large CRC consortia with available information on dietary folate, supplemental folic acid, and total folate intake were included. Colorectal tumor samples from cases were sequenced for the presence of nonsilent mutations in 105 genes and 6 signaling pathways (IGF2/PI3K, MMR, RTK/RAS, TGF-β, WNT, and TP53/ATM). Multinomial logistic regression models were analyzed comparing mutated/nonmutated CRC cases to controls to compute multivariable-adjusted odds ratios (ORs) with 95% confidence interval (CI). Heterogeneity of associations of mutated compared with nonmutated CRC cases was tested in case-only analyses using logistic regression. Analyses were performed separately in hypermutated and nonhypermutated tumors, because they exhibit different clinical behaviors. RESULTS: We included 4339 CRC cases (702 hypermutated tumors, 16.2%) and 11,767 controls. Total folate intake was inversely associated with CRC risk (OR = 0.93; 95% CI: 0.90, 0.96). Among hypermutated tumors, 12 genes (AXIN2, B2M, BCOR, CHD1, DOCK3, FBLN2, MAP3K21, POLD1, RYR1, TET2, UTP20, and ZNF521) showed nominal statistical significance (P < 0.05) for heterogeneity by mutation status, but none remained significant after multiple testing correction. Among these genetic subtypes, the associations between folate variables and CRC were mostly inverse or toward the null, except for tumors mutated for DOCK3 (supplemental folic acid), CHD1 (total folate), and ZNF521 (dietary folate) that showed positive associations. We did not observe differential associations in analyses among nonhypermutated tumors, or according to the signaling pathways. CONCLUSIONS: Folate intake was not differentially associated with CRC risk according to mutations in the genes explored. The nominally significant differential mutation effects observed in a few genes warrants further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, Imperial College London, School of Public Health, London, United Kingdom. Electronic address: k.aglago@imperial.ac.uk.
- Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
- Department of Radiation Sciences, Oncology Unit, Umeå University, Umeå, Sweden.
- Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States; Department of Epidemiology, University of Washington, Seattle, WA, United States.
- Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States; Department of Oncologic Pathology, Dana-Farber Cancer Institu…
- Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States; Department of Biostatistics, University of Washington, Seattle, WA, United States.
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
- World Health Organization
- WCRF International
- NIH ORIP
- NCI
- World Cancer Research Fund International
- Ministry of Science and Innovation, New Zealand
Zitieren
APA
Aglago, E. K., Qu, C., Harlid, S., Phipps, A. I., Steinfelder, R. S., Ogino, S., Thomas, C. E., Hsu, L., Toland, A. E., Brenner, H., Berndt, S. I., Buchanan, D. D., Campbell, P. T., Cao, Y., Chan, A. T., Drew, D. A., Figueiredo, J. C., French, A. J., Gallinger, S., …, & Peters, U. (2024). Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing. The American Journal of Clinical Nutrition, 120(3), 664-673. https://doi.org/10.1016/j.ajcnut.2024.07.012
Vancouver
Aglago EK, Qu C, Harlid S, Phipps AI, Steinfelder RS, Ogino S, et al. Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing. The American Journal of Clinical Nutrition. 2024;120(3):664-673. doi:10.1016/j.ajcnut.2024.07.012
BibTeX
@article{Aglago2024,
author = {Aglago, Elom K and Qu, Conghui and Harlid, Sophia and Phipps, Amanda I and Steinfelder, Robert S and Ogino, Shuji and Thomas, Claire E and Hsu, Li and Toland, Amanda E and Brenner, Hermann and Berndt, Sonja I and Buchanan, Daniel D and Campbell, Peter T and Cao, Yin and Chan, Andrew T and Drew, David A and Figueiredo, Jane C and French, Amy J and Gallinger, Steven and Georgeson, Peter and Giannakis, Marios and Goode, Ellen L and Gruber, Stephen B and Gunter, Marc J and Harrison, Tabitha A and Hoffmeister, Michael and Huang, Wen-Yi and Hullar, Meredith Aj and Huyghe, Jeroen R and Jenkins, Mark A and Lynch, Brigid M and Moreno, Victor and Murphy, Neil and Newton, Christina C and Nowak, Jonathan A and Obón-Santacana, Mireia and Sun, Wei and Ugai, Tomotaka and Um, Caroline Y and Zaidi, Syed H and Tsilidis, Konstantinos K and van Guelpen, Bethany and Peters, Ulrike},
title = {Folate intake and colorectal cancer risk according to genetic subtypes defined by targeted tumor sequencing},
journal = {The American Journal of Clinical Nutrition},
year = {2024},
volume = {120},
number = {3},
pages = {664--673},
doi = {10.1016/j.ajcnut.2024.07.012}
}
EUVIMED